# Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

> **NCT00152308** · PHASE4 · TERMINATED · sponsor: **Translumina GmbH** · enrollment: 333 (estimated)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** 2% rapamycin-eluting YUKONdes PEARL-stent
- **DEVICE:** 1% rapamycin-eluting YUKONdes PEARL-stent
- **DEVICE:** YUKONdes PEARL-stent coated with placebo (ethanol)

## Key facts

- **NCT ID:** NCT00152308
- **Lead sponsor:** Translumina GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 333 (ESTIMATED)
- **Why stopped:** Slow enrolement
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152308, "Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00152308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*